{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:12:13Z","timestamp":1790633533225,"version":"4.1.0"},"reference-count":22,"publisher":"ALUNA","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:p>Aim: The relevance of the study is determined by the objective of finding an optimal type of diagnostics of carbohydrate metabolism, that would assess the condition of a diabetic patient undergoing treatment. The purpose of the study is to create a model for monitoring the efficacy of diabetes mellitus treatment by determining the fructosamine levels. \nMaterials and Methods: The methods for investigating the highlighted issue are clinical examination and laboratory diagnosis of diabetic patients to measure the state of carbon metabolism using ion-exchange chromatography to determine glycated haemoglobin levels and an automatic colorimetric method to determine fructosamine levels. \nResults: The study presents certain values of fructosamine over the level of changes in the state of patients with diabetes mellitus, reflecting the progress from the treatment in the compensation of carbohydrate metabolism, which allows creating a model of diagnostic values of the fructosamine levels, according to which the efficacy of treatment of diabetes mellitus, the state of progress of the disease in its compensation or decompensation are determined at a qualitative level. \nConclusions: This allows for the timely adaptive corrective therapeutic and preventive measures to be carried out by medical personnel, who, using values, will monitor the efficacy of treatment in each patient once every three weeks, as this will determine the influence of the type of conducted treatment or other factors aimed at compensating for pathogenetic and clinical manifestations of the disease, which makes the identified fructosamine criteria an important component in the treatment of diabetes mellitus, and indirectly allows to improve the life quality of this patient population, thus bringing a practical solution to the challenge facing the healthcare sector.<\/jats:p>","DOI":"10.36740\/merkur202304109","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T17:25:36Z","timestamp":1695749136000},"page":"350-357","source":"Crossref","is-referenced-by-count":2,"title":["FRUCTOSAMINE VALUES IN MONITORING COMPENSATION AND EFFICACY OF DIABETES MELLITUS TREATMENT"],"prefix":"10.36740","volume":"51","author":[{"given":"Natalya","family":"Akhetova","sequence":"first","affiliation":[{"name":"DEPARTMENT OF ENDOCRINOLOGY, ASFENDIYAROV KAZAKH NATIONAL MEDICAL UNIVERSITY, ALMATY, REPUBLIC OF KAZAKHSTAN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abylaiuly","family":"Zhangentkhan","sequence":"additional","affiliation":[{"name":"DEPARTMENT OF ENDOCRINOLOGY, ASFENDIYAROV KAZAKH NATIONAL MEDICAL UNIVERSITY, ALMATY, REPUBLIC OF KAZAKHSTAN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Bolshakova","sequence":"additional","affiliation":[{"name":"DEPARTMENT OF ENDOCRINOLOGY, ASFENDIYAROV KAZAKH NATIONAL MEDICAL UNIVERSITY, ALMATY, REPUBLIC OF KAZAKHSTAN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainagul","family":"Beissova","sequence":"additional","affiliation":[{"name":"DIABETES CENTER, \u201cAAA\u201d MEDICAL CLINIC, ALMATY, REPUBLIC OF KAZAKHSTAN; AL FARABI KAZAKH NATIONAL UNIVERSITY, ALMATY, REPUBLIC OF KAZAKHSTAN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22436","published-online":{"date-parts":[[2023]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"1. McIntyre HD, Catalano P, Zhang C et al. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47. doi:10.1038\/s41572-019-0098-8.","DOI":"10.1038\/s41572-019-0098-8"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Si J, Yu C, Guo Y et al. Season of birth and the risk of type 2 diabetes in adulthood: a prospective cohort study of 0.5 million Chinese adults. Diabetologia. 2017;60(5):836-842. doi:10.1007\/s00125-016-4200-4.","DOI":"10.1007\/s00125-016-4200-4"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Preston EV, Eberle C, Brown FM et al. Climate factors and gestational diabetes mellitus risk - a systematic review. Environ Health. 2020;19(1):112. doi:10.1186\/s12940-020-00668-w.","DOI":"10.1186\/s12940-020-00668-w"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Wang P, Wu CS, Li CY et al. Seasonality of gestational diabetes mellitus and maternal blood glucose levels: Evidence from Taiwan. Medicine (Baltimore). 2020;99(41):e22684. doi:10.1097\/MD.0000000000022684.","DOI":"10.1097\/md.0000000000022684"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Chiefari E, Pastore I, Puccio L et al. Impact of Seasonality on Gestational Diabetes Mellitus. Endocr Metab Immune Disord Drug Targets. 2017;17(3):246-252. doi:10.2174\/1871530317666170808155526.","DOI":"10.2174\/1871530317666170808155526"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Zimmet P, Shi Z, El-Osta A et al. Chinese famine and the diabetes mellitus epidemic. Nat Rev Endocrinol. 2020;16(2):123. doi:10.1038\/s41574-019-0300-9.","DOI":"10.1038\/s41574-019-0300-9"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Chen X, Wu J, Li R et al. The establishment of adult reference intervals on fructosamine in Beijing. J Clin Lab Anal. 2016;30(6):1051-1055. doi:10.1002\/jcla.21979.","DOI":"10.1002\/jcla.21979"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Ferenci T, Sapi J, Kovacs L. Modelling tumor growth under angiogenesis in-hibition with mixed-effects models. Acta Polytechnica Hungarica. 2017;14(1):221-234. doi:10.12700\/APH.14.1.2017.1.15.","DOI":"10.12700\/aph.14.1.2017.1.15"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Bondia J, Romero-Vivo S, Ricarte B et al. Insulin estimation and prediction: a review of the estimation and prediction of subcutaneous insulin pharmacokinetics in closed-loop glucose control. IEEE Control Systems Magazine. 2018;38(1):47-66. doi:10.1109\/MCS.2017.2766312.","DOI":"10.1109\/mcs.2017.2766312"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Messori M, Incremona GP, Cobelli C et al. Individualized model predictive control for the artificial pancreas: in silico evaluation of closed-loop glucose con\u00actrol. IEEE Control Systems Magazine. 2018;38(1):86-104. doi:10.1109\/MCS.2017.2766314.","DOI":"10.1109\/mcs.2017.2766314"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Agarwal MM. Gestational diabetes in the Arab gulf countries: sitting on a land-mine. Int J Environ Res Public Health. 2020;17(24):9270. doi:10.3390\/ijerph17249270.","DOI":"10.3390\/ijerph17249270"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"12. Liu H, Chen X, Shi T et al. Association of famine exposure with the risk of type 2 diabetes: A meta-analysis. Clin Nutr. 2020;39(6):1717-1723. doi:10.1016\/j.clnu.2019.08.002.","DOI":"10.1016\/j.clnu.2019.08.002"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Luo W, Xie Y. Economic growth, income inequality and life expectancy in China. Soc Sci Med. 2020;256:113046. doi:10.1016\/j.socscimed.2020.113046.","DOI":"10.1016\/j.socscimed.2020.113046"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Yi L, Wei C, Fan W. Fine-particulate matter (PM2.5), a risk factor for rat gestational diabetes with altered blood glucose and pancreatic GLUT2 expression. Gynecol Endocrinol. 2017;33(8):611-616. doi:10.1080\/09513590.2017.1301923.","DOI":"10.1080\/09513590.2017.1301923"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"15. Chen M, Liang S, Qin X et al. Prenatal exposure to diesel exhaust PM2.5 causes offspring \u03b2 cell dysfunction in adulthood. Am J Physiol Endocrinol Metab. 2018;315(1):E72-E80. doi:10.1152\/ajpendo.00336.2017.","DOI":"10.1152\/ajpendo.00336.2017"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Yang D, Qiu J, Qin A et al. Blood glucose level, gestational diabetes mellitus and maternal birth season: a retrospective cohort study. Front Endocrinol (Lausanne). 2021;12:793489. doi:10.3389\/fendo.2021.793489.","DOI":"10.3389\/fendo.2021.793489"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Baldo FD, Magna L, Dondi F et al. Comparison of serum fructosamine and glycated hemoglobin values for assessment of glycemic control in dogs with diabetes mellitus. Am J Vet Res. 2020;81(3):233-242. doi:10.2460\/ajvr.81.3.233.","DOI":"10.2460\/ajvr.81.3.233"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Sivasubramaniyam S, Amiel SA, Choudhary P. Proportion of daily capillary blood glucose readings required in the target range for target glycaemic control: shift of focus from target range to proportion in range. Diabet Med. 2017;34(10):1456-1460. doi:10.1111\/dme.13438.","DOI":"10.1111\/dme.13438"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Kalaria TR, Sirajwala HB, Gohel MG. Serum fructosamine, serum glycated albumin and serum glycated \u03b2-lipoprotein in type 2 diabetes mellitus patients with and without microvascular complications. J Diabetes Metab Disord. 2016;15:53. doi:10.1186\/s40200-016-0276-0.","DOI":"10.1186\/s40200-016-0276-0"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Malmstr\u00f6m H, W\u00e4ndell PE, Holzmann MJ et al. Low fructosamine and mortality - a long term follow-up of 215,011 non-diabetic subjects in the Swedish AMORIS study. Nutr Metab Cardiovasc Dis. 2016;26(12):1120-1128. doi:10.1016\/j.numecd.2016.08.006.","DOI":"10.1016\/j.numecd.2016.08.006"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Dworacka M, Iskakova S, Weso\u0142owska A, Zharmakhanova G, Stelmaszyk A, Frycz BA, Jagodzi\u0144ski PP, Dworacki G. Simvastatin attenuates the aberrant expression of angiogenic factors induced by glucose variability. Diabetes Res. Clin. Pract. 2018;143:245-253.","DOI":"10.1016\/j.diabres.2018.07.023"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Tazhbenova ST, Millere I, Yermukhanova LS, Sultanova G, Turebaev M, Sultanova BP. Effectiveness of diabetes mellitus management program at primary health care level. Electron J Gen Med 2019;16(6):em172.","DOI":"10.29333\/ejgm\/115848"}],"container-title":["Polski Merkuriusz Lekarski"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T17:08:31Z","timestamp":1698599311000},"score":1,"resource":{"primary":{"URL":"https:\/\/polskimerkuriuszlekarski.pl\/wp-content\/uploads\/library\/PolMerkurLek2023i4.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023]]},"published-print":{"date-parts":[[2023,8]]}},"URL":"https:\/\/doi.org\/10.36740\/merkur202304109","archive":["Internet Archive"],"relation":{},"ISSN":["1426-9686"],"issn-type":[{"value":"1426-9686","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}